Multivariate analysis revealed that the grade of tumor differentiation and immunohistochemical expression of Grx2 were independent prognostic factors for the survival of patients with colon adenocarcinoma, as shown in Table 4 of our patient cohort data. This evidence concerns the gene GLRX2 and neoplasm.